Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

Patient Safety Spotlight: managing the risks associated with providing community pharmacy clinical services

24 January 2023
In this article, co-produced by one of our specialist inspectors Aileen O’Hare and Helen Williams, Consultant Pharmacist for CVD, South-East London ICS, we highlight the GPhC standards to focus on...

New Pride in Pharmacy resources

24 January 2023
Pharmacy teams have a crucial role in addressing the health inequalities faced by LGBTQ+* communities including barriers to accessing healthcare, experience of prejudice and discrimination, and...

New equality guidance for pharmacies

24 January 2023
The new guidance is designed to help tackle discrimination and ensure everyone can access safe and effective person-centred care. The new equality guidance will help support pharmacy owners and their...

Good clinical governance in an online pharmacy setting

4 October 2022
In this article Aileen O’Hare, one of our specialist inspectors, shares examples of good clinical governance in an online pharmacy setting, which have been identified through our inspection work....

Tackling patient safety concerns when providing pharmacy services online

4 October 2022
With a growing demand for online pharmacy services, models of delivery are developing rapidly - which means pharmacy and other healthcare services are being delivered in new and innovative ways. This...